Catalyst Wire Dossier Catalyst Wire Dossier

nivolumab (Bristol-Myers Squibb Pharma EEIG)

nivolumab · Bristol-Myers Squibb Pharma EEIG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for nivolumab (Bristol-Myers Squibb Pharma EEIG), covering 2016-01-14 to 2016-01-14. Get the full timeline:

Most recent: EMA Withdrawn: Nivolumab BMS (nivolumab) — Bristol-Myers Squibb Pharma EEIG

See pricing